OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Naeem F. Qusty, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 67, pp. 102008-102008
Open Access | Times Cited: 61
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Naeem F. Qusty, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 67, pp. 102008-102008
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hany Akeel Al-Hussaniy, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108516-108516
Open Access | Times Cited: 146
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hany Akeel Al-Hussaniy, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108516-108516
Open Access | Times Cited: 146
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 75
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 75
The potential role of neopterin in Covid-19: a new perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 4161-4166
Open Access | Times Cited: 68
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 4161-4166
Open Access | Times Cited: 68
Niclosamide for Covid-19: bridging the gap
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8195-8202
Open Access | Times Cited: 56
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8195-8202
Open Access | Times Cited: 56
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 55
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 55
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Marwa S. Al‐Niemi, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1651-1667
Open Access | Times Cited: 51
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Marwa S. Al‐Niemi, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1651-1667
Open Access | Times Cited: 51
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
The crucial role of prolactin-lactogenic hormone in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Monica Butnariu, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 5, pp. 1381-1392
Open Access | Times Cited: 39
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Monica Butnariu, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 5, pp. 1381-1392
Open Access | Times Cited: 39
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112193-112193
Open Access | Times Cited: 46
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112193-112193
Open Access | Times Cited: 46
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
Shenghua Gao, Tianguang Huang, Letian Song, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 581-599
Open Access | Times Cited: 44
Shenghua Gao, Tianguang Huang, Letian Song, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 581-599
Open Access | Times Cited: 44
Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 41
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 41
Potential role of lipoxin in the management of COVID-19: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1993-2001
Open Access | Times Cited: 32
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1993-2001
Open Access | Times Cited: 32
Ginkgo biloba in the management of the COVID‐19 severity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Levamisole Therapy in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Viral Immunology (2021) Vol. 34, Iss. 10, pp. 722-725
Closed Access | Times Cited: 33
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Viral Immunology (2021) Vol. 34, Iss. 10, pp. 722-725
Closed Access | Times Cited: 33
Vinpocetine is the Forthcoming Adjuvant Agent in the Management of COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Muyiwa Samuel Fageyinbo, et al.
Future Science OA (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 26
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Muyiwa Samuel Fageyinbo, et al.
Future Science OA (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 26
Calprotectin: The Link Between Acute Lung Injury and Gastrointestinal Injury in Covid-19: Ban or Boon
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 5, pp. 310-320
Closed Access | Times Cited: 22
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 5, pp. 310-320
Closed Access | Times Cited: 22
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sadiq M. Al‐Hamash, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sadiq M. Al‐Hamash, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail
Shadi Alkhayyat, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammation Research (2022) Vol. 71, Iss. 10-11, pp. 1159-1167
Open Access | Times Cited: 22
Shadi Alkhayyat, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammation Research (2022) Vol. 71, Iss. 10-11, pp. 1159-1167
Open Access | Times Cited: 22
Maternal Transmission of SARS-CoV-2: Safety of Breastfeeding in Infants Born to Infected Mothers
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Francis O. Atanu, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 31
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Francis O. Atanu, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 31
Dantrolene and ryanodine receptors in COVID ‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 10
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 10
Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Nermeen N. Welson, et al.
International Journal of Clinical Pharmacy (2022) Vol. 44, Iss. 3, pp. 832-833
Open Access | Times Cited: 17
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Nermeen N. Welson, et al.
International Journal of Clinical Pharmacy (2022) Vol. 44, Iss. 3, pp. 832-833
Open Access | Times Cited: 17
Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
